News Type: Publications

  • August 13, 2021

Lykan and Vineti Form Cell Therapy Agreement

Publication: Contract Pharma

Partnership will streamline process development and manufacturing to deliver therapies to patients in need.

  • August 3, 2021

Uncharted Podcast #94, Democratizing healthcare and the importance of continuous learning with Amy DuRoss, CEO and Co-founder of Vineti by Uncharted Podcast

Publication: Uncharted Podcast

Amy DuRoss, CEO and Co-founder of Vineti, a committed patient advocate, is blazing a trail to orchestrate the supply chain...

  • July 15, 2021

PharmaVoice 100 Entrepreneurs

Publication: PharmaVoice 100

These visionary leaders recognized an opportunity to fill an industry need and are successfully leading their companies to new heights.

  • May 28, 2021

Industry News: Ori Biotech and Vineti have formed strategic partnership to deliver integrated manufacturing and supply chain solutions for cell and gene therapies

Publication: Select Science

Ori Biotech, an innovator in cell and gene therapy manufacturing, and Vineti, a provider of leading digital enterprise platforms for cell and gene therapy supply…

  • May 26, 2021

Ori Biotech and Vineti collaborate on digital platform for CGTs

Publication: Manufacturing Chemist

Ori Biotech and Vineti are partnering to produce an integrated solution to streamline the manufacture and delivery of cell and gene therapies (CGTs).

Ori provides…

  • April 20, 2021

McKesson Ventures highlights investment priorities amidst a trail of successful exits

Publication: MedCity News

McKesson Ventures is one of the most active investors in the biopharma software sector with Vineti, Komodo Health, Evidation and M2Gen among its portfolio companies.…

  • April 8, 2021

Meeting on the Med 2021 | International collaboration in advanced therapies


Amy DuRoss, Co-Founder & CEO, Vineti, San Francisco, CA, explains that the scientific community’s response to the COVID-19 pandemic has...

  • April 8, 2021

Meeting on the Med 2021 | What can the field learn from the COVID-19 pandemic?


Amy DuRoss, Co-Founder & CEO, Vineti, San Francisco, CA, discusses the lessons that the field of cell and gene therapy...

  • April 1, 2021

Six Cell and Gene Therapy Commercialization Trends


Amy DuRoss, CEO and Co-founder, Vineti and Keith Martino, VP/General Manager, Biopharma Services, Cardinal Health Specialty Solutions discuss what to watch in the next 12…

  • March 24, 2021

Biopharmaceutical and technology leaders form collaboration to promote standards and a modern patient ID for advanced therapies

Publication: Globe Newswire

SAN FRANCISCO, March 24, 2021 (GLOBE NEWSWIRE) -- A broad coalition of biopharmaceutical and technology leaders today announced a new strategic collaboration to promote new…

  • March 24, 2021

Exclusive: An industry consortium wants to standardize cell tracking for regenerative meds. Could that avert a disaster?

Publication: Endpoints News

In the fast-moving world of regenerative medicine, the open secret among industry experts is that manufacturing is exceedingly difficult and will take a Herculean effort…